News and Comments

Biogen: A Fruitful Collaboration in Gene Therapy. A Small Gene Therapy Firm That You Should Know

  Tuesday, May 17, 2016

COLLABORATIONS  More...

Biogen Idec Pays Elan $3.25 billion For Tysabri. Do We Leave, Or Stay?

  Wednesday, February 06, 2013

 More...

Elan's Choices

  Saturday, April 16, 2011

Biogen Idec (BIIB) announced positive results of a process aimed at Identifying high-risk patients for a life-threatening side effect of prolonged use of the multiple sclerosis drug Tysabri. This test is a necessity because it detects an antibody that points to the presence of the Polyomavirus JC (JC virus), which causes the life-threatening progressive multifocal leukoencephalopathy (PML). This side effect in one per thousand patients has deprived Elan from billions of dollars in expected sales of Tysabri.  More...


Recent Postings


Archive


Tags

Editas (EDIT) Sangamo (SGMO) Ziofpharm (ZIOP) Exelixis (EXEL) Prolor Biotech (PBTH) OSI (OSIP) ACADIA (ACAD) Bristol-Myers Squibb (BMY) Agenus (AGEN BIOMARIN (BMRN) RenenxBio (RGNX) SYNTA (SNTA) Idenix (IDIX) Xoma (XOMA) Ionis (IONS) VANDA (VNDA) Incyte (INCY) ARGOS (ARGS) ZALTRAP™ Trastuzumab-DM1 ABBVIE (ABBV) Sanofi (SNA) Sanofi (SNY) Gilead (GILD) Zerenex Intermune (ITMN) Array Pharmaceuticals (ARRY) Genentech Theravance (THRX) Multiple Myeloma REGULUS (RGLS) Tysabri PTC Therapeutics (PTCT) Spike Therapeutics (ONCE) ARCA (ABIO) Alder Biopharmaceuticals (ALDR) Sarepta (SRPT) Micromet (MITI) galapagos (GLPG) Aimmune Therapeutics (AIMT) Sanofi-Aventis (SAN) Ridaforolimus Pluristem (PSTI) Biocryst (BCRX) JUNO (JUNO) ImmunoGen (IMGN) Inovio (INO) CompuGen (CGEN) Onyx (ONXX) TOKAI (TKAOI) KITE (KITE) Intrexon (XON) SERES THERAPEUTICS (MCRB) ISIS (ISIS) Dynavax (DVAX) HALOZYME (HALO) Jazz Pharmaceuticals (JAZZ) Alnylam (ALNY) Roche (ROCHE) INNOVIVA (INVA) Theravance Bio Pharma (TBPH) Cytokinetics (CYTK) Valeant Pharmaceuticals International (VRX) Human Longevity (HLI) Mirati Therapeutics (MRTX) GUARDIAN HEALTH ADVENTRIX (ANX) Biogen Idec (BIIB) Merck (MRK) Intercept (ICPT) Global Cell Therapeutics (GBT) GlaxoSmithKline (GSK) NEKTAR (NKTR)) Herceptin KERYX (KERX) Seattle Genetics (SGEN) Roche (RHHBY) Amgen (AMGN) Dendreon (DNDN) Endometrial Cancer Galena (GALE) Agenus (AGEN) Telaprevir AERIE PHARMACEUTICALS Regeneron (REGN) Illumina (ILMN) IDERA (IDRA) Rapamune Revlimid (lenolidamide) Vitae Pharmaceuticals (VTAE) Prosensa (RNA) NANTKWEST (NK) Benlysta (belimumab) Anadys (ANDS) Abbott Laboratories (ABT) AGOS (ARGS) Velcade (bortezomib) Elan (ELN) Vertex (VRTX) Auspex (ASPX) Anacor (ANAC) C4 Therapeutics Sequenom (SQNM) Human Genome Sciences (HGSI) Ariad (ARIA) SUNESIS PHARMACEUTICALS (SNSS)